Key terms
About DGX
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest DGX news
Today
7:20am ET
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), Tactile Systems Technology (TCMD) and Danaher (DHR)
Today
6:40am ET
Wall Street Analysts Are Neutral on Top Healthcare Picks
Yesterday
9:37am ET
Quest Diagnostics: Strong Q1 Outperformance Spurs Buy Rating and Raised Full-Year Guidance
Yesterday
6:50am ET
Quest Diagnostics raises FY24 adjusted EPS view $8.72-$8.97 from $8.60-$8.90
Yesterday
6:46am ET
Quest Diagnostics reports Q1 adjusted EPS $2.04, consensus $1.85
Apr 22
8:25pm ET
Notable companies reporting before tomorrow’s open
Apr 22
1:26pm ET
Notable companies reporting before tomorrow’s open
Apr 22
7:55am ET
Quest Diagnostics launches blood biomarker test for Alzheimer’s diagnosis
Apr 16
5:57am ET
Barclays Remains a Hold on Quest Diagnostics (DGX)
Apr 02
7:59am ET
Quest Diagnostics and Broad Clinical Labs announce collaboration
Mar 31
5:25am ET
Ex-Dividend Date Nearing for These 10 Stocks – Week of April 1, 2024
Mar 20
7:15am ET
Truist Financial Sticks to Their Hold Rating for Quest Diagnostics (DGX)
Mar 18
8:25am ET
Quest Diagnostics management to meet with UBS
Feb 26
9:34am ET
Moderna downgraded, Gap upgraded: Wall Street’s top analyst calls
Feb 26
6:12am ET
Quest Diagnostics initiated with a Market Perform at Leerink
Feb 21
8:07am ET
Quest Diagnostics and Instacart announce collaboration
Feb 08
7:38am ET
Piper Sandler Remains a Hold on Quest Diagnostics (DGX)
Feb 08
7:34am ET
Quest Diagnostics price target raised to $145 from $140 at Piper Sandler
Feb 07
10:32am ET
Amgen downgraded, Enphase upgraded: Wall Street’s top analyst calls
Feb 07
5:03am ET
Quest Diagnostics upgraded to Buy from Hold at Jefferies
Feb 02
8:52am ET
Quest Diagnostics price target lowered to $125 from $140 at Deutsche Bank
Feb 02
8:30am ET
Quest Diagnostics price target lowered to $145 from $150 at Truist
Feb 02
6:49am ET
Quest Diagnostics price target lowered to $150 from $165 at Mizuho
Feb 02
6:46am ET
Quest Diagnostics price target lowered to $136 from $140 at Baird
Feb 02
5:41am ET
Analysts Are Bullish on These Healthcare Stocks: Quest Diagnostics (DGX), Becton Dickinson (BDX)
Feb 02
5:37am ET
Quest Diagnostics price target lowered to $138 from $145 at Barclays
Feb 02
3:37am ET
Barclays Keeps Their Hold Rating on Quest Diagnostics (DGX)
Feb 01
8:51pm ET
Quest Diagnostics price target lowered to $135 from $145 at Citi
Feb 01
8:20pm ET
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), Sarepta Therapeutics (SRPT) and Regeneron (REGN)
Feb 01
7:13am ET
Quest Diagnostics increases quarterly dividend 5.6% to 75c per share
Feb 01
7:11am ET
Quest Diagnostics sees FY24 adjusted EPS $8.60-$8.90, consensus $8.99
Apr 15
9:15am ET
Q4HE Initiative Recognized for Efforts To Reduce Health Disparities
Apr 09
12:00pm ET
My Quest Story - Jessica Clow
Apr 01
2:30pm ET
My Quest Story - Pauline Chaves
Mar 26
12:30pm ET
She Is Not Skipping a Beat, and Patients Are Noticing
Mar 20
11:15am ET
My Quest Story - Eddy Hurst
Mar 14
1:20pm ET
Quest Colleague Is Exhibiting Care for Every Patient in Her Chair
DGX Financials
Key terms
Ad Feedback
DGX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
DGX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
